In atrial fibrillation, single-nucleus multi-omics implicated androgen-receptor signaling in cardiomyocytes and NR4A1 regulation in fibroblasts, suggesting hormonal modulators as potential interventions in atrial cardiomyopathy (Leblanc et al., 2025). This evidence concerns the gene AR and atrial fibrillation.